HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637H909. A total of 3 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $10,029,000 | -55.7% | 4,950 | -62.0% | 0.91% | -38.3% |
| Q3 2017 | $22,645,000 | +157.2% | 13,037 | +89.9% | 1.48% | +156.9% |
| Q2 2017 | $8,803,000 | +109.1% | 6,867 | +111.4% | 0.58% | +153.7% |
| Q1 2017 | $4,209,000 | +57.3% | 3,248 | +19.9% | 0.23% | +45.5% |
| Q4 2016 | $2,676,000 | -54.8% | 2,708 | -44.7% | 0.16% | -29.7% |
| Q3 2016 | $5,920,000 | +226.5% | 4,901 | +133.3% | 0.22% | +133.7% |
| Q2 2016 | $1,813,000 | -5.6% | 2,101 | +3.5% | 0.10% | -1.0% |
| Q1 2016 | $1,921,000 | -72.4% | 2,029 | -49.5% | 0.10% | -74.9% |
| Q4 2015 | $6,956,000 | +29.0% | 4,014 | 0.0% | 0.38% | +72.5% |
| Q3 2015 | $5,391,000 | -40.5% | 4,014 | 0.0% | 0.22% | -32.9% |
| Q2 2015 | $9,064,000 | +81.2% | 4,014 | +14.6% | 0.33% | +59.1% |
| Q1 2015 | $5,001,000 | +376.7% | 3,502 | +400.3% | 0.21% | +210.4% |
| Q4 2013 | $1,049,000 | – | 700 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 246,000 | $6,595,000 | 0.03% |
| SIMPLEX TRADING, LLC | 1,214 | $3,254,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |